AI shortens drug discovery to around 1 year in China, Insilico CEO says | WTVB

Insilico Medicine has reduced drug discovery timelines to 9-13 months by combining AI with China-based research operations, undercutting traditional Western pharma development cycles of 4.5+ years. The model highlights how AI plus China's lower costs and streamlined regulation are reshaping competitive advantage in drug development.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.